American Academy of Pediatrics Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2001
NCT00353184
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

American Academy of Pediatrics | American Academy of Pediatrics Section of Neonatal-Perinatal Medicine

Active Ingredients

Drugs in Phase 2 Trials (2)

glucose monohydrate (1 trial)

sodium chloride (1 trial)

Drugs in Other Trials (2)

montelukast (singulair) (1 trial)

oxygen (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dehydration (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4